Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Breast Cancer

Free Subscription 10.08.2026 1 AJR Am J Roentgenol 1 Am J Clin Oncol 1 Am J Pathol 7 Ann Surg Oncol 1 BMC Cancer 3 Br J Cancer 4 Breast Cancer 2 Breast Cancer (Dove Med Press) 6 Breast Cancer Res Treat 1 Cancer 2 Cancer Epidemiol Biomarkers Prev 1 Cancer Res 7 Clin Breast Cancer 1 Clin Cancer Res 1 Clin Med Insights Oncol 1 Eur J Cancer 1 Eur Radiol 4 Histopathology 2 Int J Cancer 1 J Clin Invest 2 J Nucl Med 1 Mol Ther Oncol 1 Pathology 1 PLoS One 2 Pol J Radiol 2 Proc Natl Acad Sci U S A 1 Radiology 1 Semin Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. CAPIRO N, Milch HS
   Mammography-Based Deep Learning Model Better Than Breast Density at Predicting Breast Cancer Risk.
   AJR Am J Roentgenol. 2026 Aug 5. doi: 10.2214/AJR.26.35634.
   PubMed        
   
   

   
   Am J Clin Oncol

2. OFORI-DARKO A, Walker M, Burnette UJ, McClelland S 3rd, et al
   Navigation and Care Coordination in Breast Cancer: Early Findings From a Phase I Clinical Trial.
   Am J Clin Oncol. 2026 Aug 3. doi: 10.1097/COC.0000000000001357.
   PubMed         Abstract available
   
   

   
   Am J Pathol

3. RAO VR, Sadanandappa MK, Black CC, Palisoul SM, et al
   An Explanatory Deep Learning Pipeline for the Prediction and Visualization of Spatially Resolved Biomarker Expression in Triple-Negative Breast Cancer.
   Am J Pathol. 2026 Aug 7:S0002-9440(26)00229-4. doi: 10.1016/j.ajpath.2026.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

4. TSENG J, Dimitroff K, Sauder CAM, Chien AJ, et al
   Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial.
   Ann Surg Oncol. 2026 Aug 3. doi: 10.1245/s10434-026-20153.
   PubMed         Abstract available
   
   
5. TAYLOR N, Chew YL, Ng TS, Palesty JA, et al
   Recurrence in Real Time: Rethinking Breast Cancer Follow-Up Evaluation with Circulating Tumor DNA.
   Ann Surg Oncol. 2026 Aug 3. doi: 10.1245/s10434-026-20252.
   PubMed         Abstract available
   
   
6. KAWASHIMA K, Chida K, Oshi M, Yamada A, et al
   ASO Visual Abstract: A Neuron Projection Guidance Signature Associates With Immune-Cold Tumor Microenvironment and Poor Outcomes in Breast Cancer.
   Ann Surg Oncol. 2026 Aug 6. doi: 10.1245/s10434-026-20348.
   PubMed        
   
   
7. BLACK DM, Glasgow AE, Degnim AC, Hieken TJ, et al
   ASO Visual Abstract: Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer by Age, Race, and Tumor Subtype.
   Ann Surg Oncol. 2026 Aug 5. doi: 10.1245/s10434-026-20346.
   PubMed        
   
   
8. EUM JL, Smilen SH, Barmettler G, Boolbol SK, et al
   HER2 Copy Number Predicts Treatment Response in Patients with Breast Cancer: A NCDB Study.
   Ann Surg Oncol. 2026 Aug 4. doi: 10.1245/s10434-026-20367.
   PubMed        
   
   
9. CHEN JH, Peregrin-Alvarez I, Warneke CL, McKenzie LJ, et al
   ASO Author Reflections: Can We Preserve Fertility without Compromising Oncologic Outcomes?: Preoperative Oncofertility for ER-Positive Breast Cancer.
   Ann Surg Oncol. 2026 Aug 4. doi: 10.1245/s10434-026-20373.
   PubMed        
   
   
10. ZAVERI S, Whitham Z, Nguyen A, Nadar A, et al
    ASO Visual Abstract: Variation in Surgical Management of Stage IV Breast Cancer-Local/Institutional and Regional Geographic Considerations.
    Ann Surg Oncol. 2026 Aug 3. doi: 10.1245/s10434-026-20244.
    PubMed        
    
    

    
    BMC Cancer

11. YU L, Shi Q, Jin Y, Liu Z, et al
    Retraction Note: Blockage of AMPK-ULK1 pathway mediated autophagy promotes cell apoptosis to increase doxorubicin sensitivity in breast cancer (BC) cells: an in vitro study.
    BMC Cancer. 2026;26:944.
    PubMed        
    
    

    
    Br J Cancer

12. DENNISON RA, Valasaki M, Wright S, Frost R, et al
    Priorities for breast cancer risk assessment in UK women under age 50: a survey and discrete choice experiment.
    Br J Cancer. 2026 Aug 4. doi: 10.1038/s41416-026-03546.
    PubMed         Abstract available
    
    
13. FROST R, Ficorella L, Berrington de Gonzalez A, Antoniou AC, et al
    Comparison of NICE criteria with the BOADICEA multifactorial risk model to guide breast cancer risk assessment and referral amongst women under age 50 within primary care.
    Br J Cancer. 2026 Aug 4. doi: 10.1038/s41416-026-03547.
    PubMed         Abstract available
    
    
14. CELLAI C, Laurenzana A, Vannucchi AM, Caporale R, et al
    Editorial Expression of Concern: Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086.
    Br J Cancer. 2026 Aug 7. doi: 10.1038/s41416-026-03582.
    PubMed        
    
    

    
    Breast Cancer

15. ALTAWALBEH SM, Gharaibeh M, Alothman L, Wateska AR, et al
    Cost-effectiveness of mammography-based breast cancer screening in Jordan: a healthcare system perspective.
    Breast Cancer. 2026 Aug 7. doi: 10.1007/s12282-026-01904.
    PubMed         Abstract available
    
    
16. ONDER T, Ates O
    Crossing the milestone: landmark-based conditional survival after first-line CDK4/6 inhibitor therapy in HR+/HER2-metastatic breast cancer.
    Breast Cancer. 2026 Aug 7. doi: 10.1007/s12282-026-01903.
    PubMed         Abstract available
    
    
17. YAO N, Xu G, Duan N, Han F, et al
    Next-generation endocrine therapy in HR+/HER2 - breast cancer: oral SERDs, ER-targeting innovations, and ctDNA-driven ESR1 mutation-guided switching.
    Breast Cancer. 2026 Aug 7. doi: 10.1007/s12282-026-01900.
    PubMed         Abstract available
    
    
18. JING L, Lun J, Xu J, Jin Z, et al
    PTX3 induces the expression of PD-L1 and promotes breast cancer immune escape.
    Breast Cancer. 2026 Aug 3. doi: 10.1007/s12282-026-01902.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

19. WANG Y, Cai Q
    Exosomal miR-21 Derived from Paclitaxel-Resistant Breast Cancer Cells Promotes Chemoresistance in Breast Cancer via p53/PI3K/AKT/mTOR Signaling.
    Breast Cancer (Dove Med Press). 2026;18:615413.
    PubMed         Abstract available
    
    
20. HORRMANN A, Travadi Y, Carey J, Boytim E, et al
    Development and Validation of a Machine-Learning Deep Plasma Proteome Classifier for Early-Stage Breast Cancer Detection.
    Breast Cancer (Dove Med Press). 2026;18:609238.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

21. VOORTHUIS RAB, Opdam M, Ter Hoeve ND, Silva MD, et al
    Invasive lobular breast cancer in young patients without adjuvant systemic treatment: 15-year survival outcomes.
    Breast Cancer Res Treat. 2026;218:31.
    PubMed         Abstract available
    
    
22. SUN W, Li H, Zhao X, Hu S, et al
    Optimising screening intervals and BI-RADS management pathways in ultrasound-based breast cancer screening: real-world evidence from Shenzhen (2018-2023).
    Breast Cancer Res Treat. 2026;218:33.
    PubMed         Abstract available
    
    
23. FOULAD D, Tsai J, Luo I, Xu A, et al
    Locoregional recurrence and mortality after breast cancer surgery in patients aged 85 and older.
    Breast Cancer Res Treat. 2026;218:32.
    PubMed         Abstract available
    
    
24. TRAINA TA, Serra E, Bedard J, Levesque-Leroux M, et al
    First-line treatment patterns and real-world survival outcomes in PD-L1-negative locally recurrent inoperable or metastatic triple-negative breast cancer in the United States.
    Breast Cancer Res Treat. 2026;218:30.
    PubMed         Abstract available
    
    
25. ALI M
    Methodological considerations on the predictive value of tumor-infiltrating lymphocytes for pathological complete response in early triple-negative breast cancer.
    Breast Cancer Res Treat. 2026;218:28.
    PubMed        
    
    
26. DOSUNMU GT, Omoleye O, Huo D, Giurcanu M, et al
    Birth cohort differences in reproductive and lifestyle breast cancer risk factors among women in the Nigerian breast cancer study.
    Breast Cancer Res Treat. 2026;218:29.
    PubMed         Abstract available
    
    

    
    Cancer

27. HUANG L, Cook LS, Tang MC, Doody DR, et al
    Relationship between bisphosphonate use and risks of recurrence and mortality among hormone receptor-positive and triple-negative breast cancer patients.
    Cancer. 2026;132:e70562.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

28. NOWAK SA, Emery J, Ziller E, Sowden M, et al
    Individual-Level Trends in Mammography Screening over 14 years: Results from an All-Payer Statewide Claims Database.
    Cancer Epidemiol Biomarkers Prev. 2026;35:1386-1391.
    PubMed         Abstract available
    
    
29. CHEN S, Kerlikowske K, Su YR, Hubbard RA, et al
    Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2026;35:1375-1385.
    PubMed         Abstract available
    
    

    
    Cancer Res

30. NAPOLITANO F, Hanker AB
    Shaping CDK4/6 Inhibitor Resistance: BRCA2 Germline Alterations Bias toward RB1 Inactivation.
    Cancer Res. 2026;86:3631-3633.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

31. DORTEN P, Windgassen S, Radke I, Opitz C, et al
    Re-excision in Ductal Carcinoma In Situ Is Not Associated With Improved Local Control: A Retrospective Cohort Study.
    Clin Breast Cancer. 2026;26:152-157.
    PubMed         Abstract available
    
    
32. PARK E, Eilfer S, Klosterman K, Calderon-Tellez S, et al
    The Effects of Radiation Treatment in Breast Cancer Patients on the Subsequent Development of Adhesive Capsulitis.
    Clin Breast Cancer. 2026;26:196-200.
    PubMed         Abstract available
    
    
33. HAMAM NG, Samir M, Almosilhy NA, Whdan MM, et al
    Metformin as a Neoadjuvant to Chemotherapy in Locally Advanced and Metastatic Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Clin Breast Cancer. 2026;26:1-13.
    PubMed         Abstract available
    
    
34. GRIECO F, Driutti M, Zanin E, Bassi E, et al
    Long-Term Clinical Outcomes and Cost-Utility Analysis of Prepectoral Versus Subpectoral Implant-Based Breast Reconstruction Following Nipple-Sparing Mastectomy: A Multicenter Retrospective Cohort Study.
    Clin Breast Cancer. 2026;26:82-89.
    PubMed         Abstract available
    
    
35. ALEXOVIC M, Sabo J, Bouchal P
    Patients With Luminal Breast Carcinoma: The State of the Field in Proteomic and Proteogenomic Molecular Subtyping.
    Clin Breast Cancer. 2026;26:96-111.
    PubMed         Abstract available
    
    
36. KIM DK, Warner MM, Zhang A, Bogue JT, et al
    Association of Regional Anesthesia With Reduced Post-discharge Opioid Prescriptions Following Immediate Autologous Breast Reconstruction: An ACS-NSQIP Analysis.
    Clin Breast Cancer. 2026;26:145-151.
    PubMed         Abstract available
    
    
37. ALTHAWADI R, Albuainain RY, Ali NF, Isa A, et al
    Is Breast Conserving Surgery Oncologically Safe for Patients With Multiple Ipsilateral Breast Cancers? A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2026;26:49-56.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

38. SHENG JY, Zahurak ML, Too F, Montanari A, et al
    Weight Loss Responses to Pharmacotherapy in Breast Cancer Survivors: Results from the Adaptive Nutrition and Exercise Weight loss (A-NEW) Study.
    Clin Cancer Res. 2026 Aug 4. doi: 10.1158/1078-0432.CCR-26-0270.
    PubMed         Abstract available
    
    

    
    Clin Med Insights Oncol

39. TAN Z, Liu S, Zhao D, Du S, et al
    Stromal Laminin Subunit Alpha 3 is a Novel Prognostic Marker for Breast Cancer.
    Clin Med Insights Oncol. 2026;20:11795549261476199.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

40. HEROLD N, Engel C, Speiser D, Ripperger T, et al
    Spectrum of double heterozygosity in individuals diagnosed with hereditary breast and ovarian cancer.
    Eur J Cancer. 2026;244:116874.
    PubMed         Abstract available
    
    

    
    Eur Radiol

41. KILBURN-TOPPIN F, Rothwell J, Payne NR, Huang Y, et al
    A comparison of tumour characteristics of screen-detected and interval cancers and their relationship with breast density and AJCC prognostic stage in a UK screening cohort.
    Eur Radiol. 2026;36:7221-7230.
    PubMed         Abstract available
    
    

    
    Histopathology

42. WANG Y, Hart J, Canepa M, Treaba DO, et al
    Histological assessment of treatment effect in lymph node-positive breast cancer after neoadjuvant chemotherapy.
    Histopathology. 2026 Aug 4. doi: 10.1111/his.70256.
    PubMed         Abstract available
    
    
43. LOPEZ-GARCIA MA, Galan L, Melendez B, Eizaguirre B, et al
    Secretory carcinoma of the breast: a report of six cases with different immunophenotypes and molecular subtypes.
    Histopathology. 2026;89:533-543.
    PubMed         Abstract available
    
    
44. RAKHA EA, Provenzano E, Kingham A, Bennet R, et al
    Borderline breast lesions and the limits of classification: insights from the UK National Breast Screening EQA scheme.
    Histopathology. 2026;89:479-494.
    PubMed         Abstract available
    
    
45. DEMAN F, Broeckx G, Degotte Q, Siozopoulou V, et al
    Optimizing breast core needle biopsy biomarker throughput using an AI-based workflow.
    Histopathology. 2026;89:495-503.
    PubMed         Abstract available
    
    

    
    Int J Cancer

46. REINER AS, Malone KE, Lynch CF, Mellemkjaer L, et al
    Risk Factors for Estrogen Receptor Subtype-Specific Contralateral Breast Cancer in Women Under Age 55 Years.
    Int J Cancer. 2026 Aug 7. doi: 10.1002/ijc.70683.
    PubMed         Abstract available
    
    
47. LEI Q, Schmidt ME, Zimmer P, Meyer P, et al
    Assessment of Cancer-Related Cognitive Impairments Across Anti-Cancer Therapies in a Predominantly Breast Cancer Cohort.
    Int J Cancer. 2026 Aug 7. doi: 10.1002/ijc.70691.
    PubMed         Abstract available
    
    

    
    J Clin Invest

48. RADLER PD, Felsheim BM, Fernandez-Martinez A, Pfefferle AD, et al
    Molecular evaluation of residual disease following neoadjuvant chemotherapy in triple negative breast cancer CALGB40603 (Alliance).
    J Clin Invest. 2026 Aug 4:e205962. doi: 10.1172/JCI205962.
    PubMed         Abstract available
    
    

    
    J Nucl Med

49. JIA W, Yan T, An S, Zhang Y, et al
    Immuno-PET/CT Imaging of Trop2 Expression with [(18)F]AlF-RESCA-RT4 Enhances Diagnosis of Breast Cancers and the Metastases.
    J Nucl Med. 2026 May 14:jnumed.125.271093. doi: 10.2967/jnumed.125.271093.
    PubMed         Abstract available
    
    
50. GAO S, Zhang Z, Shi C, Cheng C, et al
    (68)Ga-HER2 PET/CT for Predicting Pathologic Response to Neoadjuvant Therapy at Early Treatment and Preoperative Stages in HER2-Positive Breast Cancer: A Prospective Study.
    J Nucl Med. 2026 Aug 6:jnumed.125.271529. doi: 10.2967/jnumed.125.271529.
    PubMed         Abstract available
    
    

    
    Mol Ther Oncol

51. LI LT, Zhao FF, Jia ZM, Qi LQ, et al
    Retraction Notice to: Cannabinoid receptors promote chronic intermittent hypoxia-induced breast cancer metastasis via IGF-1R/AKT/GSK-3beta.
    Mol Ther Oncol. 2026;34:201302.
    PubMed         Abstract available
    
    

    
    Pathology

52. POLCHAI N, Ndeke D, Alshammari K, Greener MR, et al
    Retrospective assessment of TCF12 expression in early invasive breast cancer and ovarian cancer: prognostic implications and biological insights.
    Pathology. 2026 Aug 4:S0031-3025(26)00563-5. doi: 10.1016/j.pathol.2026.
    PubMed         Abstract available
    
    

    
    PLoS One

53. ARTHUR P, Boamah Mensah AB, Boamah Mensah K, Konney TO, et al
    Gatekeepers or barriers? Exploring traditional medicine practitioners' understanding of breast cancer in Ghana.
    PLoS One. 2026;21:e0355289.
    PubMed         Abstract available
    
    

    
    Pol J Radiol

54. MEHRABI M, Salek N
    Retracted: Enhancing diagnostic accuracy in breast cancer: integrating novel machine learning approaches with enhanced image preprocessing for improved mammography analysis.
    Pol J Radiol. 2026;91:e320.
    PubMed         Abstract available
    
    
55. XU R, Miao Z, Zuo X, Lu L, et al
    The role of magnetic resonance imaging (MRI) in breast cancer molecular subtypes.
    Pol J Radiol. 2026;91:e288-e298.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

56. 
    Retraction for Khan et al., Macrophage TBK1 signaling drives the development and outgrowth of breast cancer brain metastasis.
    Proc Natl Acad Sci U S A. 2026;123:e2625886123.
    PubMed        
    
    
57. LIU X, Liu Y, Li J, Wang Z, et al
    High-throughput deformability-based microfluidic sorting reveals metastatic cancer subpopulations.
    Proc Natl Acad Sci U S A. 2026;123:e2604094123.
    PubMed         Abstract available
    
    

    
    Radiology

58. DORFNER FJ, Dorster MA, Connolly R, Gentilhomme O, et al
    DBT-DINO: Toward Foundation Model-Based Analysis of Digital Breast Tomosynthesis.
    Radiology. 2026;320:e254034.
    PubMed         Abstract available
    
    

    
    Semin Oncol

59. YILDIRIM I, Avci CB
    Exosomes as emerging biomarkers in breast, lung, and colorectal cancer diagnosis: A comprehensive review.
    Semin Oncol. 2026;53:152497.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum